HER3 mediates acquired resistance to HER2-targeted therapy in esophageal adenocarcinoma

被引：1
|
作者：
Ebbing, Eva A. [1 ]
Medema, Jan Paul [1 ]
Meijer, Sybren L. [1 ]
Krishnadath, Kausilia K. [1 ]
Henegouwen, Mark I. van Berge [1 ]
Bijlsma, Maarten F. [1 ]
van Laarhoven, Hanneke W. M. [1 ]
机构：
[1] AMC, Amsterdam, Netherlands
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-350
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
350
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling
    Moody, S. E.
    Schinzel, A. C.
    Singh, S.
    Izzo, F.
    Strickland, M. R.
    Luo, L.
    Thomas, S. R.
    Boehm, J. S.
    Kim, S. Y.
    Wang, Z. C.
    Hahn, W. C.
    ONCOGENE, 2015, 34 (16) : 2061 - 2071
  • [32] Acquired resistance to HER2 targeted therapy: A common mechanism
    Christenson, Jessica
    Kane, Susan E.
    CANCER RESEARCH, 2012, 72
  • [33] PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling
    S E Moody
    A C Schinzel
    S Singh
    F Izzo
    M R Strickland
    L Luo
    S R Thomas
    J S Boehm
    S Y Kim
    Z C Wang
    W C Hahn
    Oncogene, 2015, 34 : 2061 - 2071
  • [34] A central role for HER3 in HER2-amplified breast cancer:: implications for targeted therapy
    Lee-Hoeflich, Si Tuen
    Crocker, Lisa
    Yao, Evelyn
    Pham, Thinh
    Munroe, Xander
    Hoeflich, Klaus P.
    Sliwkowski, Mark X.
    Stern, Howard M.
    CANCER RESEARCH, 2008, 68 (14) : 5878 - 5887
  • [35] Blocking a key region in the HER2 subdomain III inhibits the HER2-network in patients with resistance to HER2-targeted therapy
    Schroeder, Barbara
    Javier, Menendez
    Ingrid, Espinoza
    Ruth, Lupu
    CANCER RESEARCH, 2015, 75
  • [36] Molecular Basis of HER2-Targeted Therapy for HER2-Positive Colorectal Cancer
    Yoshikawa, Ayumu
    Nakamura, Yoshiaki
    CANCERS, 2023, 15 (01)
  • [37] Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer
    Nahta, Rita
    Yu, Dihua
    Hung, Mien-Chie
    Hortobagyi, Gabriel N.
    Esteva, Francisco J.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (05): : 269 - 280
  • [38] Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
    Rita Nahta
    Dihua Yu
    Mien-Chie Hung
    Gabriel N Hortobagyi
    Francisco J Esteva
    Nature Clinical Practice Oncology, 2006, 3 : 269 - 280
  • [39] HER2-targeted gene transfer
    Foster, BJ
    Kern, JA
    HUMAN GENE THERAPY, 1997, 8 (06) : 719 - 727
  • [40] Cutaneous Adnexal Adenocarcinoma: Genomic Analysis and Successful HER2-targeted Therapy of Metastatic Disease
    Hirano-Lotman, Yui
    Ishida, Yoshihiro
    Endo, Yuichiro
    Ogawa, Seishi
    Kabashima, Kenji
    ACTA DERMATO-VENEREOLOGICA, 2023, 103
12345